The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
D000818:Animals; D000908:Antibodies, Fungal / Q000032:analysis; D000946:Antigens, Fungal / Q000302:isolation & purification; D001665:Binding Sites; D001798:Blood Proteins / Q000032:analysis; D002469:Cell Separation; D002473:Cell Wall; D003165:Complement System Proteins / Q000302:isolation & purification / Q000378:metabolism*; D003453:Cryptococcosis / Q000276:immunology*; D003454:Cryptococcus / Q000276:immunology*; D003455:Cryptococcus neoformans / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D009504:Neutrophils; D010587:Phagocytosis; D011134:Polysaccharides / Q000378:metabolism
D000908:Antibodies, Fungal; D000946:Antigens, Fungal; D001798:Blood Proteins; D007074:Immunoglobulin G; D011134:Polysaccharides; D003165:Complement System Proteins